- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 71.83M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.01B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $651.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.51B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.02B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.7B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.16B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 73.56M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $55.93M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $27.24M |
| Capex | Q1 2025 · Mar 31, 2024 | $6.26M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $81.93M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $4.72B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $4.61B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $2.53 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $2.56 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $50.73M |
| Net Income | Q1 2025 · Mar 31, 2024 | $186.02M |